Beirne Wealth Consulting Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,163
| Closed | -$275K | – | 171 |
|
|
2020
Q4 | $275K | Buy |
1,163
+115
| +11% | +$27.2K | 0.14% | 117 |
|
|
2020
Q3 | $285K | Buy |
+1,048
| New | +$285K | 0.17% | 100 |
|
|
2019
Q3 | – | Sell |
-1,154
| Closed | -$212K | – | 140 |
|
|
2019
Q2 | $212K | Sell |
1,154
-958
| -45% | -$176K | 0.19% | 120 |
|
|
2019
Q1 | $389K | Sell |
2,112
-355
| -14% | -$65.4K | 0.31% | 107 |
|
|
2018
Q4 | $409K | Buy |
+2,467
| New | +$409K | 0.35% | 94 |
|